Riskpilot← Back to searchSign inGet full accessCanopus Medical AB
ABBankruptOrg 5590477229LundManufacture of basic pharmaceutical products · NACE 2110Est. 20160 employees
Revenue 2024
SEK 8,8M
-26% vs 2023
EBITDA margin
-38.7%
-402% vs 2023
Equity ratio
-144.6%
Financial strength
Net profit 2024
SEK -11,9M
-2383% vs 2023
| Revenue | SEK 8,8M | -26% |
| EBITDA | SEK -3,4M | -402% |
| Net profit | SEK -11,9M | -2383% |
| Total assets | SEK 5,6M | -67% |
| Equity | SEK -8,1M | -264% |
| Employees | 0 | — |
Legal name
Canopus Medical AB
Org number
5590477229
Legal form
Aktiebolag
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
19 januari 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten Styrelsen ska bestå av 2 styrelseledamöter och 2 styrelsesuppleanter. Då minst halva antalet styrelsesuppleanter ska vara bosatta inom EES uppfyller företaget inte längre bosättningskravet.
Company purpose
Bolaget skall tillverka och idka handel med medicinska, diagnostiska, farmaceutiska och kemisk-tekniska produkter, och idka därmed förenlig verksamhet.
Address
Lund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 261 | 9 015 | 12 049 | 11 909 | 8 837 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −4 079 | 265 | 2 037 | 1 131 | −3 420 |
| Depreciation & amort. | −459 | −519 | −614 | −581 | −8 338 |
| EBIT | −4 538 | −254 | 1 423 | 550 | −11 758 |
| Net financials | −5 | −9 | −2 | −29 | −136 |
| Profit before tax | −4 544 | −263 | 1 422 | 521 | −11 894 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −4 544 | −263 | 1 422 | 521 | −11 894 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 372 | 10 594 | 13 556 | 16 930 | 5 619 |
| Equity | 91 | 957 | 3 749 | 4 970 | −8 127 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 282 | 9 637 | 9 807 | 11 960 | 13 746 |
| Total debt | 8 282 | 9 637 | 9 807 | 11 960 | 13 746 |
EBITDA margin
-38.7%
This company
15.8%
Market median
-345% vs market
20202024
Equity ratio
-144.6%
This company
38.2%
Market median
-479% vs market
20202024
Return on equity
-1189400000.0%
This company
18.4%
Market median
-6464130535% vs market
20202024
Net profit margin
-134.6%
This company
8.1%
Market median
-1762% vs market
20202024
Asset turnover
1.57×
This company
1.12×
Market median
+40% vs market
20202024
Debt / equity
1.69×
This company
0.62×
Market median
-173% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AF | Audit | 2021 |
| Former (1) | ||
KG Chief Auditor | Chief Auditor | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
InnoLund Partners AB
Canopus Medical AB Board members of Canopus Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Gustav Alexander Englund | Chief Auditor | 0 companies |
| Anders Filip Lundberg | Audit | 0 companies |
| H E Makramalla | Deputy Board Member | 0 companies |
| Hussein Ismail | Board of Directors | 0 companies |
| Ali Almofadhi | Deputy Board Member | 0 companies |
| Ali Mohamad Ismail | Chairman | 0 companies |